The variability of levodopa response in Parkinson's disease: is sensitization reversible?
Jabre
Mazen G
MG
Bejjani
Boulos-Paul W
BP
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D018491:Dopamine Agonists / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy* / Q000473:pathology; D010479:Pergolide / Q000627:therapeutic use*; D016896:Treatment Outcome
D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D010479:Pergolide; D007980:Levodopa